Braun Stacey Associates Inc. Trims Position in Lam Research Corporation $LRCX

Braun Stacey Associates Inc. lowered its stake in Lam Research Corporation (NASDAQ:LRCXFree Report) by 3.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 155,268 shares of the semiconductor company’s stock after selling 5,512 shares during the period. Lam Research makes up approximately 1.9% of Braun Stacey Associates Inc.’s holdings, making the stock its 10th largest holding. Braun Stacey Associates Inc.’s holdings in Lam Research were worth $67,282,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Brighton Jones LLC grew its holdings in shares of Lam Research by 1,032.4% in the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after purchasing an additional 12,936 shares during the last quarter. Caxton Associates LLP bought a new stake in Lam Research during the 1st quarter valued at $239,000. Gabelli Funds LLC purchased a new stake in Lam Research during the 2nd quarter valued at $253,000. NewEdge Advisors LLC boosted its position in Lam Research by 2.7% during the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after buying an additional 2,661 shares during the period. Finally, Osterweis Capital Management Inc. grew its holdings in Lam Research by 5,206.7% in the 2nd quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock worth $77,000 after acquiring an additional 781 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Lam Research Trading Down 5.2%

Shares of LRCX opened at $301.90 on Friday. Lam Research Corporation has a 1-year low of $94.11 and a 1-year high of $438.50. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The firm’s 50-day moving average price is $330.43 and its 200-day moving average price is $289.14. The firm has a market capitalization of $377.77 billion, a price-to-earnings ratio of 52.41, a PEG ratio of 1.26 and a beta of 1.84.

Lam Research (NASDAQ:LRCXGet Free Report) last released its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the prior year, the firm earned $1.33 earnings per share. Lam Research’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 9.32 EPS for the current year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be given a $0.33 dividend. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. This is an increase from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s dividend payout ratio is currently 18.06%.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research broke ground on a 120,000-square-foot Oregon semiconductor laboratory as part of a planned investment of more than $3 billion in its global lab network over five years. The project is intended to accelerate process innovations for advanced AI chips and improve collaboration with customers, supporting the company’s long-term growth prospects. Lam Research breaks ground on AI semiconductor lab in Oregon
  • Positive Sentiment: The board approved a 27% increase in the quarterly dividend, from $0.26 to $0.33 per share. The payout is scheduled for October 14, 2026, for shareholders of record on September 23, providing a modest shareholder-return signal. Lam Research Corporation Announces a 27% Increase in Quarterly Dividend
  • Neutral Sentiment: Lam’s latest earnings exceeded consensus expectations, with quarterly earnings per share of $1.82 versus the $1.69 estimate and revenue of $6.72 billion. Revenue increased 30% year over year, while management issued fiscal first-quarter 2027 EPS guidance of $2.00 to $2.30. Analysts’ median price target remains substantially above recent trading levels, although Mizuho recently lowered its target to $365.
  • Neutral Sentiment: Two long-serving directors, Michael R. Cannon and Sohail U. Ahmed, plan to retire from the board on November 2, 2026. The transition could refresh governance but introduces some near-term uncertainty regarding board composition. Lam Research Announces Retirement of Michael R. Cannon and Sohail U. Ahmed from Board of Directors
  • Negative Sentiment: Investors appear increasingly concerned about tariffs, export restrictions and other U.S.-China trade measures. China was Lam’s largest geographic market in fiscal 2026, making the company particularly sensitive to policy changes that could reduce demand, hurt margins or disrupt its supply chain. These macro concerns have overshadowed the dividend increase and Oregon expansion. Lam Research Slides as China Trade Risk Appears to Outweigh Dividend Hike
  • Negative Sentiment: Reported insider activity shows selling rather than buying by executives and directors over the past six months, which may reinforce caution among investors, though such transactions can reflect personal financial planning rather than a view on company fundamentals.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Bank of America upped their price objective on shares of Lam Research from $330.00 to $480.00 and gave the company a “buy” rating in a research note on Tuesday, June 23rd. UBS Group restated a “buy” rating and set a $375.00 price target (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $390.00 price target on shares of Lam Research in a research report on Thursday, July 30th. Stifel Nicolaus increased their price objective on Lam Research from $325.00 to $425.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Finally, Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the stock a “buy” rating in a research report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $357.31.

View Our Latest Analysis on LRCX

Insider Transactions at Lam Research

In related news, SVP Neil J. Fernandes sold 7,659 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the sale, the senior vice president directly owned 58,470 shares of the company’s stock, valued at $18,102,312. This represents a 11.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 80,441 shares of company stock valued at $27,614,296. Corporate insiders own 0.31% of the company’s stock.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Articles

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.